Cargando…

Impact of food, alcohol and pH on modified-release hydrocortisone developed to treat congenital adrenal hyperplasia

BACKGROUND: We developed a modified-release hydrocortisone, Chronocort, to replace the cortisol rhythm in patients with congenital adrenal hyperplasia. Food, alcohol and pH affect drug absorption, and it is important to assess their impact when replicating a physiological rhythm. SUBJECTS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karunasena, Nayananjani, Margetson, Daniel N, Neal, Greg, Whitaker, Martin J, Ross, Richard JM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2017
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425936/ https://www.ncbi.nlm.nih.gov/pubmed/28100629 http://dx.doi.org/10.1530/EJE-16-0948

Ejemplares similares

Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
por: Merke, Deborah P, et al.
Publicado: (2021)

Androgens correlate with increased erythropoiesis in women with congenital adrenal hyperplasia
por: Karunasena, Nayananjani, et al.
Publicado: (2016)

OR25-02 A Phase 3 Study of a Modified-Release Hydrocortisone in the Treatment of Congenital Adrenal Hyperplasia
por: Merke, Deborah P, et al.
Publicado: (2020)

RF09 | PSAT70 Comparison of Prednisolone Versus Modified-release Hydrocortisone (Efmody) in the Treatment of Congenital Adrenal Hyperplasia (CAH)
por: Merke, Deborah P, et al.
Publicado: (2022)

Nocturnal Dexamethasone versus Hydrocortisone for the Treatment of Children with Congenital Adrenal Hyperplasia
por: Dauber, Andrew, et al.
Publicado: (2010)

Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia
por: Jones, Christopher M., et al.
Publicado: (2016)

Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach
por: Michelet, Robin, et al.
Publicado: (2023)

Early Metabolic Benefits of Switching Hydrocortisone to Modified Release Hydrocortisone in Adult Adrenal Insufficiency
por: Bannon, Christopher A. M., et al.
Publicado: (2021)

SUN-358 Dual Release Hydrocortisone as a New Treatment for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Simeoli, Chiara, et al.
Publicado: (2019)

Alterations in Hydrocortisone Pharmacokinetics in a Patient With Congenital Adrenal Hyperplasia Following Bariatric Surgery
por: Mallappa, Ashwini, et al.
Publicado: (2017)

Hydrocortisone dosing in children with classic congenital adrenal hyperplasia: results of the German/Austrian registry
por: Hoyer-Kuhn, Heike, et al.
Publicado: (2021)

Results of the Prolonged Use of Subcutaneous Continuous Infusion of Hydrocortisone in a Man with Congenital Adrenal Hyperplasia
por: Sonnet, Emmanuel, et al.
Publicado: (2011)

Chronotherapy based on modified-release hydrocortisone to restore the physiological cortisol diurnal rhythm
por: Whitaker, Martin J., et al.
Publicado: (2022)

Would Cortisol Measurements Be a Better Gauge of Hydrocortisone Replacement Therapy? Congenital Adrenal Hyperplasia as an Exemplar
por: Hindmarsh, Peter C, et al.
Publicado: (2020)

Differential effects of hydrocortisone, prednisone, and dexamethasone on hormonal and pharmacokinetic profiles: a pilot study in children with congenital adrenal hyperplasia
por: Nebesio, Todd D., et al.
Publicado: (2016)

A Biopredictive In Vitro Approach for Assessing Compatibility of a Novel Pediatric Hydrocortisone Drug Product within Common Pediatric Dosing Vehicles
por: Wollmer, Erik, et al.
Publicado: (2020)

PSAT087 A de Novo Model for Measuring Long-Term Health Effects of Modified-Release Hydrocortisone Capsules in Adult and Adolescent Patients With Classic Congenital Adrenal Hyperplasia
por: Parviainen, Lotta, et al.
Publicado: (2022)

Access to fludrocortisone and to hydrocortisone in children with congenital adrenal hyperplasia in the WHO Eastern Mediterranean Region: it takes a village…
por: Rowlands, Amanda, et al.
Publicado: (2021)

A pilot study on the effect of three hydrocortisone dosing regimen on 17 hydroxyprogesterone levels in patients with congenital adrenal hyperplasia
por: Salud, Josephine Leiya Marie F, et al.
Publicado: (2013)

Congenital adrenal hyperplasia
por: Dessinioti, Cleo, et al.
Publicado: (2009)

Congenital Adrenal Hyperplasia
por: Speiser, Phyllis W.
Publicado: (2015)

Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency
por: Guarnotta, V, et al.
Publicado: (2019)

SAT-009 Proof of Concept That Corticosterone Has a Higher Therapeutic Index Than Hydrocortisone in Patients with Congenital Adrenal Hyperplasia
por: Kyle, Catriona, et al.
Publicado: (2019)

Long-term prednisone versus hydrocortisone treatment in children with classic congenital adrenal hyperplasia (CAH) and a brief review of the literature
por: Ahmed, Shaymaa Elsayed Abdel Meguid, et al.
Publicado: (2019)

Clinical advances in the pharmacotherapy of congenital adrenal hyperplasia
por: Prete, Alessandro, et al.
Publicado: (2021)

Nonclassic Congenital Adrenal Hyperplasia
por: Witchel, Selma Feldman, et al.
Publicado: (2010)

Congenital lipoid adrenal hyperplasia
por: Kim, Chan Jong
Publicado: (2014)

Effects of the therapy shift from cortisone acetate to modified-release hydrocortisone in a group of patients with adrenal insufficiency
por: Frigerio, Sofia, et al.
Publicado: (2023)

Testicular Adrenal Rest Tumours in Congenital Adrenal Hyperplasia
por: Claahsen-van der Grinten, H. L., et al.
Publicado: (2009)

Adrenal Hypoplasia Congenita Presenting as Congenital Adrenal Hyperplasia
por: Flint, Jennifer L., et al.
Publicado: (2013)

Giant Bilateral Adrenal Myelolipoma with Congenital Adrenal Hyperplasia
por: Al-Bahri, S., et al.
Publicado: (2014)

Landscape of Adrenal Tumours in Patients with Congenital Adrenal Hyperplasia
por: Carsote, Mara, et al.
Publicado: (2023)

Bone safety of dual-release hydrocortisone in patients with autoimmune primary adrenal insufficiency
por: Bioletto, Fabio, et al.
Publicado: (2023)

Modified-Release Hydrocortisone: Is It Time to Change Clinical Practice?
por: Stewart, Paul M
Publicado: (2019)

Management of the Adult with Congenital Adrenal Hyperplasia
por: Auchus, Richard J.
Publicado: (2010)

Congenital adrenal hyperplasia: Treatment and outcomes
por: Kamoun, Mahdi, et al.
Publicado: (2013)

Nonclassical Congenital Adrenal Hyperplasia and Pregnancy
por: Cuhaci, Neslihan, et al.
Publicado: (2015)

Assisted Reproduction in Congenital Adrenal Hyperplasia
por: Chatziaggelou, Anastasios, et al.
Publicado: (2019)

Novel treatments for congenital adrenal hyperplasia
por: Schröder, Mariska A. M., et al.
Publicado: (2022)

Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia
por: Lousada, Lia Mesquita, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uavrpr6d3o76d8o8b3lbpqihvi